Joint arthroplasties may be associated with a blood loss, which necessitates transfusion. Especially, hip arthroplasties are highly associate with transfusion to compensate perioperative bleeding. Orthopaedic surgeons and patients have increasing concerns regarding complications of blood transfusions. Although various methods to reduce transfusions have been attempted in TJA, a high percentage of patients require a transfusion during and after the procedures. The purposes of this study were to evaluate the trends of the transfusion(transfusion rates, transfusion amounts, economic burden) in hip arthroplasties, using nationwide data from the National Health Insurance Service (NHIS). We used data from nationwide claims database of Health Insurance Review Assessment Service (HIRA). The data managed by the NHIS were used to identify the 161,934 hip arthroplasties by 3 categories including bipolar hemiarthroplasty(BH), total hip arthroplasty(THA), and revision arthroplasty(RA) from 2007 to 2015. These 3 categories were classified using the operation code recorded in the requisition data of NHIS. The transfusion rates, transfusion amounts, proportion of transfusion, cost of each type of operation was investigated and stratified by age, gender, hospital type, and area in hip arthroplasties. The proportion of transfusion about whole blood, red blood cell, fresh frozen plasma, platelet, was also evaluated in hip arthroplasties.Aims
Patients and methods
Venous thromboembolism (VTE), including pulmonary embolism (PE) resulting from deep vein thrombosis (DVT), remains a well-known serious complication after femoral fractures. The low molecular heparin is widely used to prevent VTE. This study compared the effectiveness of VTE prevention between dalteparin and enoxaparin. From 2013 to 2014, we retrospectively recruited 712 patients who had femoral fractures with operative treatment. All patients receiving VTE chemoprophylaxis with perioperative period using dalateparin in Group 1(N=395) and enoxaparin in Group 2(N=317). The prophylactic dosing was determined using individual product labeling and identified as enoxaparin 40 mg every 12 hours and dalteparin 2500 international unit (IU) once daily, based on clinical practice guidelines. The prophylaxis was started at admission, and maintained during average 8.43.5 days after operation. The outcome including the incidence of clinically significant deep vein thrombosis, pulmonary embolism, perioperative bleeding and cost of drugs were evaluated between two groups.Introduction
Materials and Methods
Arthroplasties of hip and knee are associated with blood loss, which may lead to adverse patient outcome. Jehovah's Witnesses do not accept blood transfusion. Performing arthroplasties in Witness patients without transfusion has been a matter of concern. We developed a protocol, which avoids transfusion in arthroplasties of Witness patients, and evaluated the feasibility and safety of the protocol. Our protocol consisted of subcutaneous administration of 4000 U recombinant erythropoietin and 100 mg of intravenous iron supplements when patient's hemoglobin level was less than 10 g/dL in preoperative evaluation. During the operation, cell saver, and plasma expander were used. Postoperatively, recombinant erythropoietin was administered three times a week and iron supplements were administered daily until the hemoglobin level reached 10 g/dL. We evaluated the feasibility of our protocol, perioperative complications and hematologic changes.Introduction
Materials and Methods
In comminuted intertrochanteric fractures, various operative options have been introduced. The purpose of this study was to determine whether there were differences in clinical and radiologic outcomes among bipolar hemiarthroplasty(BH), compression hip screw(CHS) and proximal femur nail antirotatory(PFNA) in treating comminuted intertrochanteric fractures(AO type, A2(21, 22, 23)) We retrospectively evaluated total 150 patients(BH:50, CHS:50, PFNA: 50) who were operated due to intertrochanteric fractures from March 2010 to Dec 2012 and were older than 65 years at the time of surgery. We compared these three groups for radiologic and clinical outcomes at 12 months postoperatively, including Harris hip score, ability of ambulation(Koval stage), visual analogue scale and radiologic limb length discrepancy(shortening). Landmark and radiologic length was checked.
–A: postoperative length –A’: POD 1year –B: immediate posteopative contralateral length(from hip center to distal tip of lesser trochanter) –B’: POD 1year contralateral length(from hip center to distal tip of lesser trochanter) –
Limb length(shortening) was adjusted considering difference of magnification = {A × (B’/B)}− A’Introduction
Materials and Methods
Pre-operative planning for total hip replacement
(THR) is challenging in hips with severe acetabular deformities, including
those with a hypoplastic acetabulum or severe defects and in the
presence of arthrodesis or ankylosis. We evaluated whether a Rapid
Prototype (RP) model, which is a life-sized reproduction based on
three-dimensional CT scans, can determine the feasibility of THR
and provide information about the size and position of the acetabular component
in severe acetabular deformities. THR was planned using an RP model
in 21 complex hips in five men (five hips) and 16 women (16 hips)
with a mean age of 47.7 years (24 to 70) at operation. An acetabular
component was implanted successfully and THR completed in all hips.
The acetabular component used was within 2 mm of the predicted size
in 17 hips (80.9%). All of the acetabular components and femoral
stems had radiological evidence of bone ingrowth and stability at
the final follow-up, without any detectable wear or peri-prosthetic
osteolysis. The RP model allowed a simulated procedure pre-operatively
and was helpful in determining the feasibility of THR pre-operatively,
and to decide on implant type, size and position in complex THRs. Cite this article:
A variety of radiological methods of measuring
version of the acetabular component after total hip replacement (THR)
have been described. The aim of this study was to evaluate the reliability
and validity of six methods (those of Lewinnek; Widmer; Hassan et
al; Ackland, Bourne and Uhthoff; Liaw et al; and Woo and Morrey)
that are currently in use. In 36 consecutive patients who underwent
THR, version of the acetabular component was measured by three independent
examiners on plain radiographs using these six methods and compared
with measurements using CT scans. The intra- and interobserver reliabilities
of each measurement were estimated. All measurements on both radiographs
and CT scans had excellent intra- and interobserver reliability
and the results from each of the six methods correlated well with
the CT measurements. However, measurements made using the methods
of Widmer and of Ackland, Bourne and Uhthoff were significantly
different from the CT measurements (both p <
0.001), whereas
measurements made using the remaining four methods were similar
to the CT measurements. With regard to reliability and convergent
validity, we recommend the use of the methods described by Lewinnek,
Hassan et al, Liaw et al and Woo and Morrey for measurement of version
of the acetabular component.
